The family of a girl who has an incurable eye disease are fundraising for a charity backing pioneering gene therapy which could slow down her ...

Dr. Roxana Redis: Retinal organoids have shown remarkable promise, especially in cases where traditional models fall short.

Here, we used deep full-length single-cell RNA-sequencing to distinguish post-mitotic cone and rod developmental states and cone-specific features that contribute to retinoblastomagenesis. The ...

Modern technology ventures into the depths of the human eye. A recent development could transform the lives of millions of ...

The FDA has extended the review period for the BLA for NT-501 in the treatment of macular telangiectasia type 2.

Belite Bio's, Tinlarebant, targets eye diseases STGD1 and GA, showing promising results but with delayed phase 3 trial data.

Lorati Company Limited has introduced a groundbreaking advancement in the treatment of age-related macular degeneration (AMD), including both dry and wet forms, with its nano-grade eye drops. Mr.

This high-tech device allowed them to observe both the precise arrangement of cone cells in participants’ eyes and track their minute eye movements simultaneously. The team studied 16 healthy ...

seeing spots or flashes of light or wiggly lines in front of your eyes blinkered vision (loss of peripheral vision) – being able to see clearly what is straight ahead, but not what is at the sides a ...

Temporary blindness in one eye is typically a sign of an underlying health condition, such as a blood clot or stroke, that requires immediate medical attention. High blood pressure or cholesterol ...

Good news, zombie fans: The Last of Us season 2 is heading our way in 2025. This basically means that it won't be long until we reunite with Pedro Pascal's Joel and Bella Ramsey's Ellie in one of ...

ANX005 in Guillain-Barré syndrome (GBS): First-in-kind monoclonal antibody designed to block C1q and the entire classical complement pathway in both the body and the brain has the potential to be the ...